drugset / Trial / NCT00995839

Terlipressin in Septic Shock: Effects on Microcirculation

NCT00995839

Phase 2/3 Completed 60 enrolled University of Roma La Sapienza
RandomizedParallel-groupTriple-blindTreatment

Summary

The present study was conducted as a prospective, randomized study to investigate the effects of vasopressin receptor agonists terlipressin and vasopressin on systemic hemodynamics and microcirculation in patients with catecholamine-dependent septic shock.

Timeline

Start
2008-11
Primary completion
2010-02
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Terlipressin Peptide 1 ug/kg Intravenous
Subject Terlipressin Peptide 0.5 mg Intravenous
Subject Vasopressin Peptide 0.04 iu Intravenous